-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Contineum Therapeutics, Inc. annual and quarterly Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 31 Mar 2023 to 31 Dec 2025.
- Contineum Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was $14,412,000, a 81% decline year-over-year.
- Contineum Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2025 was $55,312,000, a 68% decline from 2024.
- Contineum Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $32,845,000, a 270% decline from 2023.